Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation

@article{Iglesias2005HealthcareDP,
  title={Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation},
  author={Cynthia P Iglesias and Michael F Drummond and Joan Rovira},
  journal={International Journal of Technology Assessment in Health Care},
  year={2005},
  volume={21},
  pages={1 - 14}
}
Objectives: The use of economic evaluation studies (EE) in the decision-making process within the health-care system of nine Latin American (LA) and three European countries was investigated. The aim was to identify the opportunities, obstacles, and changes needed to facilitate the introduction of EE as a formal tool in health-care decision-making processes in LA. Methods: A comparative study was conducted based on existing literature and information provided through a questionnaire applied to… 

Systematic Review of Health Economic Evaluation Studies Developed in Brazil from 1980 to 2013

A steady number of HEE have been published in Brazil since 1980 and to improve their contribution to inform national healthcare policy efforts need to be made to enhance the quality of reporting and promote improvements in the way HEEs are designed, implemented and reported.

Health economic decision-making: a comparison between UK and Spain.

OBJECTIVE This review examines the impact of economic evaluation in informing national or local policies within both jurisdictions. We focus on the factors that have made the economic evaluation

Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable?

It is more than probable that a method with system/mechanisms specifically designed to fit particular settings will be used, given a better understanding of its resistance, and proper policies and strategies to overcome the barriers applied.

Self-reported healthcare decision-makers’ attitudes towards economic evaluations of medical technologies

For consistent policy-making it is important that similar recommendations for cost-effective interventions and programs are developed at all levels and that implementation is promoted by incorporating the appropriate incentives in healthcare provision.

Are economic evaluations and health technology assessments increasingly demanded in times of rationing health services? The case of the Argentine financial crisis

The crisis seems to be a strong incentive to extend the use of HTA in Argentina, provided decision makers are aware as well as involved in the generation of local studies.

[Health economic evaluation in a local level government health care system].

There is no possibility to apply a health economic evaluation research and have the results used in a local level government health care system, because of unsolved problems of data availability as well as of data effectiveness on information systems definition and association.

Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil

Many published Brazilian cost-utility studies adhere to key recommended general methods for HEE; however, the use of QALY calculations is far from being the current international standard.

A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand.

  • Y. TeerawattananonS. Russell
  • Political Science, Medicine
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
  • 2008
Qualitative findings from research that assessed a range of policymakers' perspectives on the acceptability of using economic evaluation for the development of health-care benefit packages in Thailand are presented.

Health technology assessment for resource allocation decisions: Are key principles relevant for Latin America?

KPs seem to be very relevant to most HTA researchers and users in LA, however, the current level of application was considered uniformly poor and higher gaps were observed in principles related to the link between HTA and decision making, highlighting one of the major challenges for the countries in the region.
...

References

SHOWING 1-10 OF 55 REFERENCES

Assessing the appropriateness of combining economic data from multinational clinical trials

It is shown how available tests for interaction can be applied to economic endpoints, including cost-effectiveness ratios and net health benefits, and a characterization of possible interactions being quantitative or qualitative in nature is included.

[Cost-effectiveness of interventions for end-stage renal disease].

This study concluded that the RT offers the least expensive alternative and the greatest number of years of life gained as well as providing significant changes in the quality of life of ESRD patients.

The health economic impact of antidepressant usage from a payer's perspective: a multinational study.

The results of this investigation show that use of venlafaxine XR in most settings across Europe and the Americas will have a favourable impact on healthcare payer budgets and the overall mental health of MDD patients.

Cost-effectiveness of hypertension treatment: a population-based study.

Treatment of hypertension with diuretics or beta blockers was more cost-effective than treatment with ACE inhibitors and calcium channel blockers, and the costs of hypertension care are mainly dependent on the expenditure on blood pressure-lowering drugs.

COSTS OF FAMILY PLANNING PROGRAMMES IN FOURTEEN DEVELOPING COUNTRIES BY METHOD OF SERVICE DELIVERY

The cost effectiveness of several modes of family planning service delivery based on the cost per couple-year of protection (CYP), including commodity costs, is assessed for 1991–92 using programme

Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.

The analysis suggests that providing an influenza vaccination programme can incur a substantial net benefit for an employer, although the size of the benefit will depend upon who normally absorbs the costs of treating influenza and compensating workers for lost work time due to illness, as well as the type of company in which the immunisation programme is applied.

The National Institute for Clinical Excellence.

So much excellent and up to date research is being ignored by NICE wrt the efficacy of the traditional psychological therapies because it is either a non RCT research study or a non specific depression study.

Could fasting plasma glucose be used for screening high-risk outpatients for gestational diabetes mellitus?

A study with high-risk outpatient pregnant women in the State University Hospital of Rio de Janeiro, Brazil conducted in 1994 determined an FPG value with good sensitivity and specificity that could identify pregnant women at risk for GDM.

The cost-effectiveness of routine versus restrictive episiotomy in Argentina.

The more effective policy of restrictive episiotomy is also less costly than that of routine episiotome, and the results are robust and consistent in both provinces.
...